article thumbnail

How Echo IQ Transforms Heart Disease Diagnosis with Cutting-Edge AI

Cassling

What does the future of heart disease detection look like? EchoSolv, the groundbreaking AI platform developed by Echo IQ, is revolutionizing the detection of aortic stenosis. EchoSolv, the groundbreaking AI platform developed by Echo IQ, is revolutionizing the detection of aortic stenosis.

article thumbnail

Correlation between CT-derived fractional flow reserve and myocardial strain in ischemic heart disease patients with single coronary artery stenosis assessed based on CCTA

Frontiers in Cardiovascular Medicine

Receiver operator characteristic curve (ROC) analysis indicated that CTFFR were effective in diagnosing impaired myocardial strain, particularly LS.ConclusionThere is a strong correlation between CTFFR, which is a functional measure for assessing coronary artery stenosis, and myocardial strain.

article thumbnail

Remnant cholesterol, lipid ratios, and the severity of coronary artery lesions: a retrospective cohort study in patients with coronary heart disease

Frontiers in Cardiovascular Medicine

This study aimed to investigate the predictive value of RC and lipid ratios alone or in combination for the severity of coronary artery stenosis in patients with coronary heart disease (CHD).MethodsThe CHD patients were categorized into mild stenosis and moderate-to-severe stenosis groups.

article thumbnail

Myocardial intramural course may reduce left ventricular ejection fraction of patients suffering from coronary heart disease

Frontiers in Cardiovascular Medicine

An increasing number of studies indicate that MIC is associated with coronary heart disease (CHD). LVEF in patients of MIC-CHD was negatively correlated with the systolic stenosis degree of mural coronary artery (MCA) (r=0.6474, p=0.0123) and MIC length (r=0.5712, p=0.0414).ConclusionsThe

article thumbnail

Cleerly Launches Cleerly ISCHEMIA Solution for Heart Disease Analysis

DAIC

milla1cf Tue, 01/09/2024 - 11:32 January 9, 2024 — Cleerly , the company working to create a new standard of care for the diagnosis of heart disease, announced the launch of Cleerly ISCHEMIA , which recently received U.S. Food and Drug Administration (FDA) 510(k) medical device clearance.

Ischemia 119
article thumbnail

Peripandemic outcomes of infants treated for sentinel congenital heart diseases in England and Wales

Open Heart

Background Infants with congenital heart disease (CHD) are clinically vulnerable to cardiac deteriorations and intercurrent infections. We aimed to quantify the impact of health system disruptions during the COVID-19 pandemic, on their clinical outcomes and whether these differed by socioeconomic and ethnic subgroups.

article thumbnail

Algorithm for predicting valvular heart disease from heart sounds in an unselected cohort

Frontiers in Cardiovascular Medicine

Objective This study aims to assess the ability of state-of-the-art machine learning algorithms to detect valvular heart disease (VHD) from digital heart sound recordings in a general population that includes asymptomatic cases and intermediate stages of disease progression.